Ana LEITE DE ALMEIDA MONTEIRO DE OLIVEIRA,Sara Isabel MACEDO BAPTISTA DA SILVA,Sandra Cristina FERREIRA BORGES,Paulo Jorge PEREIRA ALVES
申请号：
US16317051
公开号：
US20190224374A1
申请日:
2017.07.12
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present disclosure relates to a novel sericin-based hydrogel wherein the silk sericin is enzymatically cross-linked for an improved treatment of wound healing, ischemic diseases or cardiovascular diseases, namely chronic wound healing, in particular diabetic wound.
